Article metrics
PDF
Other content recommended for you
- Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006
- Not robots: children's perspectives on authenticity, moral agency and stimulant drug treatments
- Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy
- Methylphenidate for ADHD rejected from the WHO Essential Medicines List due to uncertainties in benefit-harm profile
- Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance
- Determinants of inter-practice variation in ADHD diagnosis and stimulant prescribing: cross-sectional database study of a national surveillance network
- NICE guideline review: Attention deficit hyperactivity disorder: diagnosis and management (NG87)
- Early head injury and attention deficit hyperactivity disorder: retrospective cohort study
- Childhood attention-deficit/hyperactivity disorder
- NICE guideline: attention deficit hyperactivity disorder